The Turkish Medicines and Medical Devices Agency ("TITCK") recently announced the extension of the validity period of GMP certificates due to the pandemic.
The TITCK had previously decided to suspend on-site inspections in overseas production facilities due to COVID-19 restrictions. Since on-site GMP inspections are not carried out overseas, the validity period of GMP certificates is extended until December 31, 2021 and importing companies do not need to apply to the TITCK for such extension. In case the scope of the GMP certificates change, importing companies must apply to the TITCK in accordance with the relevant provisions of the Guidelines on the Applications for GMP Inspections of Overseas Production Facilities ("Guidelines").GMP certificates that the TITCK have not audited and that do not have on-site inspection decisions will not be subject to the extension.
The TITCK's announcement is available online here (in Turkish).
The TITCK continues taking active steps to guide companies in the healthcare sector. All relevant companies should carefully review and follow the TITCK's announcements and recent developments.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.